Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ECO Animal Health Group is a global pharmaceutical company specializing in the development and marketing of high-quality medicines for the livestock industry. The company's flagship product, Aivlosin, is a patented macrolide antibiotic used to treat respiratory and enteric diseases in pigs and poultry worldwide. Beyond its established antimicrobial portfolio, ECO is aggressively expanding into the preventative medicine space with a robust pipeline of vaccines for swine and poultry. Headquartered in the United Kingdom, the group maintains a strong commercial presence in major agricultural markets including China, the United States, and Brazil. The company is focused on sustainable growth through internal research and development and strategic academic collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ECO Animal Health Group.